India Glycols Ltd Valuation Shifts to Fair Amid Strong Market Performance

Valuation Metrics and Recent Grade Upgrade

As of 17 Jul 2026, India Glycols Ltd trades at ₹1,156.80, marking a 1.67% increase from the previous close of ₹1,137.85. The company’s market capitalisation remains in the small-cap category, with a Mojo Score of 54.0 and a Mojo Grade upgraded from Sell to Hold on 20 May 2026. This upgrade reflects a more balanced outlook on the stock’s valuation and growth prospects.

The P/E ratio currently stands at 26.43, a level that has shifted the valuation grade from attractive to fair. This is a significant development considering the company’s historical valuation context and peer comparisons. The price-to-book value ratio is 2.64, indicating moderate premium pricing relative to the company’s net asset value.

Comparative Analysis with Industry Peers

When benchmarked against its commodity chemicals sector peers, India Glycols’ valuation appears more reasonable. Several competitors such as Navin Fluorine International and Himadri Speciality Chemicals are classified as very expensive, with P/E ratios of 58.68 and 45.61 respectively, and EV/EBITDA multiples exceeding 36 times. Other peers like Acutaas Chemicals and Sumitomo Chemical also trade at elevated valuations, with P/E ratios above 48 and EV/EBITDA multiples near or above 38.

In contrast, India Glycols’ EV/EBITDA ratio of 14.47 is considerably lower, suggesting a more moderate enterprise valuation relative to earnings before interest, taxes, depreciation and amortisation. This positions India Glycols as a comparatively fair-valued option within a sector where many stocks command premium multiples.

Financial Performance and Return Metrics

India Glycols’ return metrics further support its valuation stance. The company’s return on capital employed (ROCE) is 10.80%, while return on equity (ROE) stands at 10.00%. These figures indicate efficient utilisation of capital and shareholder equity, though they are modest compared to some high-growth peers.

From a dividend perspective, the yield is 1.05%, offering a modest income stream to investors. The PEG ratio of 1.52 suggests that the stock’s price growth is somewhat aligned with its earnings growth, though it is higher than some peers with lower PEG ratios, indicating a fair but not undervalued status.

Stock Price Performance Versus Sensex

India Glycols has outperformed the benchmark Sensex across multiple time horizons. Over the past week, the stock surged 10.66% compared to the Sensex’s 0.58% gain. Over one month, the stock’s return was 18.55%, dwarfing the Sensex’s 0.49%. Year-to-date, India Glycols has delivered a 13.53% return while the Sensex declined by 9.43%. Over longer periods, the stock’s performance is even more impressive, with a 3-year return of 287.12% versus the Sensex’s 16.84%, and a 10-year return of 2,272.92% compared to the Sensex’s 177.29%.

Valuation Shifts Reflect Market Sentiment and Sector Dynamics

The transition from an attractive to a fair valuation grade for India Glycols is indicative of evolving market sentiment. The commodity chemicals sector has experienced heightened volatility due to fluctuating raw material costs, regulatory changes, and global demand uncertainties. These factors have influenced investor appetite for stocks within this space, leading to a recalibration of valuation multiples.

India Glycols’ current P/E of 26.43, while higher than its historical lows, remains reasonable relative to the sector’s average, which is skewed by several very expensive stocks. The P/BV of 2.64 also suggests that the market is pricing in moderate growth expectations without excessive optimism.

Quality and Growth Outlook

Despite the fair valuation, India Glycols maintains a solid operational profile. Its ROCE and ROE metrics, though not spectacular, demonstrate consistent capital efficiency. The company’s EV to capital employed ratio of 2.05 and EV to sales ratio of 2.23 further underscore a balanced valuation relative to its asset base and revenue generation.

Investors should note the PEG ratio of 1.52, which implies that earnings growth is somewhat priced into the stock, but there remains room for upside if the company can accelerate growth or improve margins. Dividend yield at 1.05% adds a modest income component, enhancing the stock’s appeal for income-oriented investors.

Peer Comparison Highlights Valuation Advantage

Among peers, India Glycols stands out for its comparatively moderate valuation. For instance, Aarti Industries and Atul are rated as fair valued but trade at P/E ratios of 44.42 and 26.53 respectively, with EV/EBITDA multiples higher than India Glycols. Other peers such as Deepak Nitrite and Fine Organic Chemicals are categorised as expensive or very expensive, with P/E ratios exceeding 38 and EV/EBITDA multiples above 25.

This relative valuation advantage positions India Glycols as a potentially more attractive option for investors seeking exposure to the commodity chemicals sector without paying a premium for growth or quality.

Investment Considerations and Outlook

India Glycols’ valuation shift to a fair grade suggests that the stock is no longer a bargain but remains reasonably priced given its fundamentals and sector context. Investors should weigh the company’s consistent returns and moderate dividend yield against the backdrop of sector volatility and competitive pressures.

The stock’s strong relative performance versus the Sensex over multiple time frames highlights its resilience and growth potential. However, the fair valuation implies limited margin for error, and any adverse developments in raw material costs or regulatory environment could impact the stock’s attractiveness.

For long-term investors, India Glycols offers a balanced risk-reward profile with sustainable growth prospects, supported by its inclusion in thematic lists such as Reliable Performers. Meanwhile, those seeking higher growth or value may explore alternatives within the sector or across market caps as suggested by portfolio optimisation tools.

Conclusion

India Glycols Ltd’s recent valuation adjustment from attractive to fair reflects a maturing market view amid a complex commodity chemicals landscape. Its P/E and P/BV ratios, while elevated from historical lows, remain competitive relative to peers, supported by solid returns and consistent stock performance. Investors should consider this fair valuation as a signal to evaluate the stock within a diversified portfolio, balancing growth potential with sector risks.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today